Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
Identificadores
Identificadores
Data de publicación
2013Título da revista
Annals of the rheumatic diseases
Tipo de contido
Artigo